OPRK1 and Respiratory insufficiency due to muscle weakness: This result resembled those respiratory effects reported by Verborgh et al. in rats [18] and Houghton et al. in dogs [12], both of which showed reduced respiratory depression to a MOR agonist by combining it with a KOR agonist.